Webinar: Identification, Screening, and Selection of Antibodies of Interest
The webinar, presented by Kelly Harrington, Jessica Biagi, and Monica Watson, demonstrates how the Dotmatics platform streamlines and accelerates the antibody selection process through easy target searching, automated assay analysis, and integration with Geneious software to create a collaborative and efficient workflow.
How to Simplify and Accelerate the Antibody Selection Process
Presenters: Kelly Harrington, Jessica Biagi, and Monica Watson
The process of selecting candidates for screening, performing analysis, and associating assay data with sequences is often cumbersome and time consuming for scientists.
The Dotmatics platform simplifies this process with:
- Easy searching and filtering of targets of interest
- Automated assay calculations and analysis
- Integrations with Geneious software to annotate, cluster, and compare result data
In this webinar, the power of the Dotmatics platform is showcased by exploring how three scientists created a collaborative, automated, and simplified workflow to expedite the antibody selection process.
Event Details
- Date: August 31, 2022
- Time: 4pm BST / 11am EDT
- Location: Online
Related
The Rise of Biotech: Why Smaller Companies Are Outpacing Big Pharma on Innovation
Smaller biotech companies are increasingly outpacing big pharmaceutical firms in new molecular entity approvals due to their greater agility, willingness to take risks, and freedom to innovate despite funding challenges, with over half of upcoming blockbuster drug launches expected from first-time launchers who face higher risks but also potential for significant success.
Assay Screening Software Solution
The Dotmatics assay screening software solution offers an efficient data management policy that prevents data loss, automates accurate and rapid test article reporting, ensures secure real-time data sharing for CROs with flexible hosting options, and streamlines discovery through open data access, advanced visualization, and compatibility with complex workflows.
Faster Workflows, Better UX, Deeper Integration: Inside ELN & Data Discovery Platform 7.1
Dotmatics ELN & Data Discovery Platform 7.1 introduces a major interface and navigation overhaul, enhanced scientific functionalities for Biology and Chemicals & Materials R&D, and seamless integration capabilities, all designed to streamline workflows, improve user experience, and enable more efficient collaboration and data-driven decision-making in scientific research and administration.
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
Dotmatics Streamlines Workflow for Antibody Research
Dotmatics has launched its Biology Solution for Antibody Discovery, a cloud-based, end-to-end software platform that integrates with popular scientific tools like Geneious, SnapGene, and GraphPad Prism to centralize data management, automate workflows, reduce errors, and accelerate antibody research amid a rapidly growing antibody therapy market projected to reach up to $700 billion by 2032.
Leveraging Informatics and Modeling Tools to Develop a Comprehensive Design Make and Test Platform
LifeArc, a UK medical research charity focused on developing diagnostics and therapeutics for diseases like cancer and autoimmune disorders, utilizes the Dotmatics Platform to integrate and streamline their entire Design-Make-Test research cycle by uniting internal and external collaborators, automating data acquisition, and providing seamless access to predictive modeling, informatics, and AI/ML tools for small molecule and antibody discovery while protecting intellectual property.